MADRID (Reuters) -Shares in Grifols jumped sharply on Wednesday morning after news website El Confidencial reported that ...

Four investment groups with ties to the family that owns about 35% of Grifols SA confirmed they are in talks with Brookfield Asset Management Ltd. over a potential offer for the Spanish blood-plasma ...

Brookfield had filed a non-binding offer on Nov. 19 for Grifols that valued the developer of human plasma-based drugs at ...

Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it was talking with shareholders, following a report from website El Confidencial that it was ...

The Grifols family has held "very preliminary talks" through several investment firms over a potential takeover bid, according to a source close to the pharmaceutical company's reference shareholders.

Canadian investment fund Brookfield (NYSE:BAM) resumed talks on a potential takeover of Spanish pharmaceuticals company Grifols ...

IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, today announced a ...

Grifols and Brookfield said they aren't in takeover talks, after a media report indicated the investment company had resumed discussions with the Grifols family--which controls the Spanish ...

Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR) Biotest AG: Delisting agreement and announced delisting tender offer eieich, March 31, 2025: Biotest AG (ISIN ...

Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols SA to shareholders of Biotest.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares in Grifols surged on Wednesday following a report that Canadian investment firm Brookfield had resumed takeover discussions with the Spanish pharmaceutical company.